Australian medical technology innovators Epiminder and Seer Medical collaborate on epilepsy seizure detection and forecasting.
Private medical technology innovators Epiminder Pty Ltd and Seer Medical Pty Ltd have signed a strategic collaboration to accelerate ultra-long term EEG monitoring so those people who suffer seizures may have an advanced digital therapeutics product to detect and forecast their seizures.
Epiminder is evaluating its Minder® ultra-long term EEG implant at St Vincent’s Hospital in Melbourne. These ultra-long term EEG recordings produce enormous data sets and require advanced algorithms and data curation to generate new insights into patient seizure patterns. Leveraging Seer Medical’s advanced capabilities in this space will enable, for the first time, specialists in this field to better understand individual patients’ circumstances and medication.
To read the full media statement, click here.